Literature DB >> 34045261

Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management.

Emanuele Garreffa1, Joanne York1, Anne Turnbull1, Denise Kendrick2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34045261      PMCID： PMC8163473          DOI： 10.3399/bjgp21X716117

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   6.302


× No keyword cloud information.
  8 in total

Review 1.  Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis.

Authors:  Heidi L Gaddey; Angela M Riegel
Journal:  Am Fam Physician       Date:  2016-12-01       Impact factor: 3.292

2.  BCG-SSI(®) vaccine-associated lymphadenitis: Incidence and management.

Authors:  Arnis Engelis; Mohit Kakar; Roberts Meikšāns; Aigars Petersons
Journal:  Medicina (Kaunas)       Date:  2016-05-30       Impact factor: 2.430

3.  Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?

Authors:  Francesca Magnoni; M Colleoni; D Mattar; G Corso; V Bagnardi; S Frassoni; G Santomauro; B A Jereczek-Fossa; P Veronesi; V Galimberti; V Sacchini; M Intra
Journal:  Ann Surg Oncol       Date:  2020-05-21       Impact factor: 5.344

Review 4.  Occult breast cancer: Where are we at?

Authors:  Adam Ofri; Katrina Moore
Journal:  Breast       Date:  2020-10-27       Impact factor: 4.380

5.  Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.

Authors:  Nishi Mehta; Rachel Marcus Sales; Kemi Babagbemi; Allison D Levy; Anika L McGrath; Michele Drotman; Katerina Dodelzon
Journal:  Clin Imaging       Date:  2021-01-19       Impact factor: 1.605

6.  Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?

Authors:  O R Mitchell; R Dave; J Bekker; P A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2021-02-15       Impact factor: 1.651

7.  Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.

Authors:  Ayah Adel Nawwar; Julie Searle; Rajiv Singh; Iain Douglas Lyburn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-04       Impact factor: 9.236

8.  Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.

Authors:  Can Özütemiz; Luke A Krystosek; An L Church; Anil Chauhan; Jutta M Ellermann; Evidio Domingo-Musibay; Daniel Steinberger
Journal:  Radiology       Date:  2021-02-24       Impact factor: 11.105
  8 in total
  2 in total

Review 1.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.

Authors:  Jihe Lim; Seun Ah Lee; Eun Kyung Khil; Sun-Ju Byeon; Hee Joon Kang; Jung-Ah Choi
Journal:  Semin Oncol       Date:  2021-10-26       Impact factor: 4.929

2.  COVID-19 vaccine associated cervical lymphadenopathy: a case series.

Authors:  Chelsea L Heaven; Lucy Barber; Omid Ahmadi; Kumanan Selvarajah; Subhaschandra Shetty
Journal:  ANZ J Surg       Date:  2022-06-10       Impact factor: 2.025
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.